Nifty

:

25044.35

Sensex

:

82055.11

72.45 (0.29%)
158.32 (0.19%)

Login

Nifty
Sensex

:
:

25044.35
82055.11

72.45 (0.29%)
158.32 (0.19%)

Medico Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

64/99

BSE: 540937 | NSE: MEDICO

Watchlist

NSE BSE

49.06

24-Jun-2025

Open
High
Low
Previous Close

49
49.62
48.15
49.52

Volume
Traded Value (lacs)
52 Week High
52 Week Low

87329
4286769.98
79.83
35.67

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

405.79
40.20
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

418.53
N/A
6.50

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.01
10.33
6.19

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.11
35.37
11.99

PAT CAGR (%)

10 Years
5 Years
3 Years

26.50
38.44
19.90

P:E (Median)

8 Years
5 Years
3 Years

-
56.49
65.59

P:BV (Average)

8 Years
5 Years
3 Years

-
9.01
10.25

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
35.34
38.70

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 41.30 41.32 -0.05% 39.49 29.77 32.65% 39.35 42.36 -7.11% 30.80 31.47 -2.13%
Expenses 34.64 36.68 -5.56% 36.38 27.04 34.54% 36.94 39.28 -5.96% 27.99 29.01 -3.52%
EBITDA 6.66 4.65 43.23% 3.11 2.73 13.92% 2.41 3.08 -21.75% 2.81 2.46 14.23%
EBIDTM 16.13% 11.24% 7.88% 9.18% 6.14% 7.26% 9.12% 7.80%
Other Income 0.29 0.58 -50.00% 1.43 0.27 429.63% 0.68 0.96 -29.17% 0.29 0.31 -6.45%
Interest 0.49 0.25 96.00% 0.28 0.22 27.27% 0.21 0.18 16.67% 0.18 0.17 5.88%
Depreciation 0.77 0.74 4.05% 0.76 0.72 5.56% 0.75 0.71 5.63% 0.75 0.71 5.63%
PBT 5.70 4.25 34.12% 3.50 2.06 69.90% 2.13 3.14 -32.17% 2.17 1.88 15.43%
Tax 1.36 1.15 18.26% 0.88 0.62 41.94% 0.58 0.72 -19.44% 0.60 0.56 7.14%
PAT 4.34 3.10 40.00% 2.62 1.44 81.94% 1.56 2.43 -35.80% 1.58 1.32 19.70%
PATM 10.51% 7.50% 6.63% 4.85% 3.95% 5.73% 5.13% 4.20%
EPS 0.52 0.37 40.54% 0.32 0.17 88.24% 0.19 0.29 -34.48% 0.19 0.16 18.75%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 150.94 144.92 140.44 121.02 122.39 88.64 97.69 61.02 54.42 66.68 50.99 Net Sales Growth 4.15% 3.19% 16.05% -1.12% 38.08% -9.26% 60.10% 12.13% -18.39% 30.77% Cost Of Goods Sold 108.33 95.70 88.33 70.74 79.37 57.38 67.79 33.50 29.35 53.00 39.24 Gross Profit 42.61 49.22 52.11 50.29 43.02 31.25 29.90 27.52 25.07 13.68 11.76 GP Margin 28.23% 33.96% 37.10% 41.56% 35.15% 35.25% 30.61% 45.10% 46.07% 20.52% 23.06% Total Expenditure 135.95 132.01 130.96 113.69 117.15 85.80 94.93 57.54 50.41 63.03 48.09 Power & Fuel Cost - 2.55 2.47 2.29 1.91 1.83 1.73 1.42 1.05 0.00 0.00 % Of Sales - 1.76% 1.76% 1.89% 1.56% 2.06% 1.77% 2.33% 1.93% 0% 0% Employee Cost - 5.92 5.68 5.41 4.50 3.83 3.32 3.89 4.42 4.25 3.41 % Of Sales - 4.09% 4.04% 4.47% 3.68% 4.32% 3.40% 6.37% 8.12% 6.37% 6.69% Manufacturing Exp. - 20.88 22.36 23.00 18.02 15.00 16.03 13.73 11.00 0.00 0.00 % Of Sales - 14.41% 15.92% 19.01% 14.72% 16.92% 16.41% 22.50% 20.21% 0% 0% General & Admin Exp. - 2.07 1.97 2.12 2.38 2.20 1.49 1.33 1.49 5.77 5.44 % Of Sales - 1.43% 1.40% 1.75% 1.94% 2.48% 1.53% 2.18% 2.74% 8.65% 10.67% Selling & Distn. Exp. - 3.93 9.60 9.03 8.30 4.80 3.86 2.82 2.69 0.00 0.00 % Of Sales - 2.71% 6.84% 7.46% 6.78% 5.42% 3.95% 4.62% 4.94% 0% 0% Miscellaneous Exp. - 0.97 0.54 1.10 2.67 0.75 0.71 0.84 0.41 0.00 0.00 % Of Sales - 0.67% 0.38% 0.91% 2.18% 0.85% 0.73% 1.38% 0.75% 0% 0% EBITDA 14.99 12.91 9.48 7.33 5.24 2.84 2.76 3.48 4.01 3.65 2.90 EBITDA Margin 9.93% 8.91% 6.75% 6.06% 4.28% 3.20% 2.83% 5.70% 7.37% 5.47% 5.69% Other Income 2.69 2.13 4.09 2.03 1.03 2.10 1.90 0.91 0.36 0.24 0.11 Interest 1.16 0.82 0.75 0.66 0.92 1.06 0.98 1.52 1.33 0.85 0.82 Depreciation 3.03 2.88 2.72 2.22 1.65 1.66 1.51 1.00 1.05 1.18 1.09 PBT 13.50 11.33 10.10 6.48 3.70 2.22 2.18 1.87 1.99 1.87 1.10 Tax 3.42 3.04 2.86 1.67 1.11 0.58 0.60 0.65 0.06 0.74 0.31 Tax Rate 25.33% 26.83% 28.32% 25.77% 30.00% 26.13% 27.52% 34.76% 3.55% 39.57% 28.18% PAT 10.10 8.29 7.24 4.81 2.59 1.63 1.57 1.22 1.63 1.13 0.79 PAT before Minority Interest 10.10 8.29 7.24 4.81 2.59 1.63 1.57 1.22 1.63 1.13 0.79 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.69% 5.72% 5.16% 3.97% 2.12% 1.84% 1.61% 2.00% 3.00% 1.69% 1.55% PAT Growth 21.83% 14.50% 50.52% 85.71% 58.90% 3.82% 28.69% -25.15% 44.25% 43.04% EPS 1.22 1.00 0.87 0.58 0.31 0.20 0.19 0.15 0.20 0.14 0.10

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 52.37 43.84 36.57 32.46 29.87 28.24 26.67 16.37 14.74 13.61 Share Capital 16.60 16.60 16.60 4.15 4.15 4.15 4.15 3.20 1.60 1.60 Total Reserves 35.77 27.25 19.98 28.31 25.72 24.09 22.52 13.17 13.14 12.01 Non-Current Liabilities 1.26 2.08 2.50 5.21 4.92 2.63 2.55 10.93 4.39 0.63 Secured Loans 0.00 0.00 0.65 4.70 4.46 2.13 1.94 2.62 0.00 0.00 Unsecured Loans 0.25 0.25 0.25 0.25 0.25 0.25 0.25 8.22 3.70 0.00 Long Term Provisions 0.00 0.06 0.05 0.10 0.00 0.00 0.09 0.07 0.00 0.00 Current Liabilities 44.58 43.15 39.57 37.95 40.48 45.45 30.17 21.11 26.41 21.51 Trade Payables 31.51 30.99 27.10 25.35 26.40 32.52 17.52 11.88 15.36 13.15 Other Current Liabilities 3.43 1.79 1.57 4.32 6.95 2.66 2.97 1.23 0.61 0.22 Short Term Borrowings 6.50 7.85 9.06 8.11 7.12 10.27 9.69 7.90 10.10 7.89 Short Term Provisions 3.13 2.53 1.84 0.17 0.01 0.00 0.00 0.09 0.34 0.25 Total Liabilities 98.21 89.07 78.64 75.62 75.27 76.32 59.39 48.41 45.54 35.75 Net Block 21.49 21.83 18.03 15.31 12.55 12.27 6.63 6.84 7.09 7.97 Gross Block 41.34 38.80 32.39 28.89 24.36 22.43 15.37 14.57 13.77 13.47 Accumulated Depreciation 19.85 16.97 14.36 13.58 11.82 10.17 8.74 7.73 6.68 5.50 Non Current Assets 22.43 22.91 19.65 17.14 18.63 17.13 13.69 10.25 8.72 9.51 Capital Work in Progress 0.00 0.07 0.00 0.00 2.28 0.90 4.37 2.76 0.00 0.00 Non Current Investment 0.20 0.00 0.00 0.11 0.15 0.15 0.24 0.29 0.51 1.04 Long Term Loans & Adv. 0.56 0.85 1.54 1.72 3.59 3.77 2.46 0.36 1.10 0.50 Other Non Current Assets 0.18 0.16 0.07 0.00 0.06 0.05 0.00 0.00 0.01 0.00 Current Assets 75.78 66.17 59.01 58.48 56.64 59.18 45.69 38.16 36.83 26.23 Current Investments 1.36 1.27 0.00 1.06 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 16.34 19.70 18.11 14.55 18.26 16.07 14.91 10.14 9.17 8.17 Sundry Debtors 49.63 36.09 30.39 27.42 23.89 29.07 17.01 18.12 19.54 7.37 Cash & Bank 0.18 0.91 2.34 2.83 1.42 0.61 0.81 0.71 0.66 1.82 Other Current Assets 8.27 0.29 0.38 0.52 13.07 13.43 12.96 9.19 7.46 8.87 Short Term Loans & Adv. 7.84 7.91 7.78 12.10 12.67 12.99 12.60 8.88 7.21 8.48 Net Current Assets 31.20 23.02 19.43 20.53 16.16 13.74 15.52 17.05 10.42 4.73 Total Assets 98.21 89.08 78.66 75.62 75.27 76.31 59.38 48.41 45.55 35.74

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 2.44 8.17 5.86 -11.31 0.97 4.94 5.10 -3.22 -3.73 -0.32 PBT 11.33 10.10 6.48 3.68 2.22 2.18 1.87 1.69 1.87 1.10 Adjustment 3.53 2.71 2.52 2.57 2.14 1.86 2.15 2.46 1.94 1.83 Changes in Working Capital -9.26 -2.15 -1.34 -16.63 -2.81 1.49 1.64 -6.56 -6.96 -2.87 Cash after chg. in Working capital 5.60 10.66 7.66 -10.38 1.54 5.53 5.66 -2.42 -3.15 0.06 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.17 -2.50 -1.79 -0.93 -0.54 -0.55 -0.55 -0.49 -0.58 -0.38 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 -0.03 -0.04 -0.02 -0.32 0.00 0.00 Cash From Investing Activity -2.68 -6.60 -1.76 -16.96 -3.08 -4.43 -4.98 -2.81 0.32 -2.15 Net Fixed Assets -2.47 -6.48 -3.50 -2.25 -3.31 -3.59 -2.41 -3.56 -0.30 -1.62 Net Investments -0.29 -1.27 1.17 -1.02 0.00 0.09 0.05 0.22 0.53 -0.71 Others 0.08 1.15 0.57 -13.69 0.23 -0.93 -2.62 0.53 0.09 0.18 Cash from Financing Activity -0.49 -1.82 -5.77 18.28 2.60 -0.55 -0.62 5.80 2.25 2.95 Net Cash Inflow / Outflow -0.73 -0.25 -1.67 -9.99 0.48 -0.04 -0.50 -0.23 -1.17 0.48 Opening Cash & Equivalents 0.91 1.17 2.83 0.00 0.16 0.21 0.71 0.66 1.82 1.34 Closing Cash & Equivalent 0.18 0.91 1.17 -9.99 0.65 0.16 0.21 0.43 0.66 1.82

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 6.31 5.28 4.41 19.55 18.00 68.05 64.27 51.16 92.15 85.09 ROA 8.85% 8.63% 6.24% 3.43% 2.15% 2.31% 2.26% 3.47% 2.78% 2.36% ROE 17.23% 18.01% 13.94% 8.31% 5.61% 5.72% 5.67% 10.47% 7.97% 7.14% ROCE 21.90% 21.88% 15.09% 10.13% 7.66% 7.79% 9.05% 9.39% 10.86% 10.01% Fixed Asset Turnover 3.62 3.95 3.95 4.60 3.79 5.17 4.13 4.04 4.90 4.03 Receivable days 107.96 86.40 87.18 76.51 109.06 86.09 103.77 120.17 73.64 47.94 Inventory Days 45.38 49.13 49.25 48.92 70.69 57.88 74.02 61.63 47.46 56.52 Payable days 119.19 120.01 135.32 119.00 187.40 94.07 94.52 101.11 88.47 110.83 Cash Conversion Cycle 34.15 15.53 1.11 6.44 -7.66 49.90 83.26 80.69 32.63 -6.38 Total Debt/Equity 0.13 0.18 0.29 0.46 0.46 0.48 0.47 1.18 0.94 0.58 Interest Cover 14.76 14.52 10.79 5.02 3.09 3.22 2.23 2.27 3.21 2.34

Top Investors:

Annual Reports:

News Update:

Medico Remedies commences work for new factory
16th May 2025, 09:24 AM

The proposed capacity is to be added within 2 years
Read More
Medico Remedies secures government order worth Rs 16.31 crore
8th Apr 2025, 16:40 PM

The company will complete the supply of the full order within 3 months
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback